Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 42 min ago
PreprintAll rights reservedbioRxiv

Chimeric antigen receptor T cell therapy targeting CD94 for cytotoxic T/NK cell malignancies

17 more authors
  1. 1The University of Texas MD Anderson Cancer Center

Related

  1. Circulating tumor DNA for prognosis in hematologic malignancies receiving immune checkpoint inhibitors or chimeric antigen receptor T-cell therapy: a systematic review and meta-analysis
    Congcong Wang, Zhibing Jiang, Jiaojiao Qiao +5
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  2. Targeting Cardiac Fibrosis with Chimeric Antigen Receptor Neutrophils Derived from Human Pluripotent Stem Cells
    Gyuhyung Jin, Shaohai Fang, Yun Chang +7
    bioRxivPreprintCC BYFull textSystems & synthetic biologybioRxivPMC
  3. Temporal dynamics of immune effector cell‐associated haematotoxicity: Linking early and late cytopenias after chimeric antigen receptor T cells
    Malvina Bichon, Roch Houot, Mana Alshehri +3
    British Journal of HaematologyPeer-reviewedCC BY 4.0Full textGeneral biologyOncologyHAL
  4. NK cells engineered with a chimeric antigen receptor delay HIV rebound and reshape HIV reservoir composition
    Yuan Shi, Izra Abbaali, William Harvey +10
    Nature CommunicationsPeer-reviewedCC BY 4.0Full textMicrobiologyCrossref
  5. Generation and in vitro functional characterization of anti-CD22 chimeric antigen receptor T cells derived from newly generated monoclonal antibody clones
    Wipawadee Ruengdej, Vichaya Chuthaphakdikun, Sirirut Jewmoung +5
    PLOS OnePeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationDevelopmental biologyPLOSPMC
BibTeX
@misc{le2026chimeric,
  title = {{Chimeric antigen receptor T cell therapy targeting CD94 for cytotoxic T/NK cell malignancies}},
  author = {C. C. Le and J. Weng and J. Liu and F. M. Aletti and X. Cherng and Y. Tang and S. Patchva and M. Richard and M. Balakumaran and M. M. Piubelli and L. M. Solis Soto and W. Lu and C.-Y. Lin and F. Chu and J. Cao and A. Rehman and K. Singh and O. Agbedia and S. Gouni and K. Chohan and F. Darbaniyan and S. Kolsuz and K. Balakrishnan and N. Saini and M. R. Green and C. R. Flowers and S. Iyer and F. Vega and S. S. Neelapu},
  howpublished = {bioRxiv},
  year = {2026},
  month = nov,
  doi = {10.64898/2026.11.12.765663},
  url = {https://www.biorxiv.org/content/10.64898/2026.11.12.765663v1},
}
RIS
TY  - UNPB
TI  - Chimeric antigen receptor T cell therapy targeting CD94 for cytotoxic T/NK cell malignancies
AU  - C. C. Le
AU  - J. Weng
AU  - J. Liu
AU  - F. M. Aletti
AU  - X. Cherng
AU  - Y. Tang
AU  - S. Patchva
AU  - M. Richard
AU  - M. Balakumaran
AU  - M. M. Piubelli
AU  - L. M. Solis Soto
AU  - W. Lu
AU  - C.-Y. Lin
AU  - F. Chu
AU  - J. Cao
AU  - A. Rehman
AU  - K. Singh
AU  - O. Agbedia
AU  - S. Gouni
AU  - K. Chohan
AU  - F. Darbaniyan
AU  - S. Kolsuz
AU  - K. Balakrishnan
AU  - N. Saini
AU  - M. R. Green
AU  - C. R. Flowers
AU  - S. Iyer
AU  - F. Vega
AU  - S. S. Neelapu
PY  - 2026
DA  - 2026/11/12
PB  - bioRxiv
DO  - 10.64898/2026.11.12.765663
UR  - https://www.biorxiv.org/content/10.64898/2026.11.12.765663v1
ER  -